wine on semaglutide GLP-1 Drugs Are Squeezing Alcohol Sales Whining about wine! | Ken

Multiple electronic databases were systematically searched, including PubMed/MEDLINE, Embase, Cochrane Library, and Google Scholar, covering publications from January 2020 to April 2025

Zhou, Z.F

So, you can rest assured that your claim is in capable hands

Clinical trials revealed significant weight loss with liraglutide at doses of up to 3.0 mg per day, with participants losing an average of 46 kg over 20 weeks, outperforming placebo and orlistat (38)

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review